Using Technology to Reduce Youth Substance Use (TEXT2)

August 28, 2026 updated by: University of California, San Francisco
The research project will focus on conducting a trial of whether a tailored SMS text-messaging intervention is efficacious in improving justice-involved youths' substance use or dual diagnosis treatment attendance and engagement.

Study Overview

Status

Completed

Conditions

Detailed Description

The study will demonstrate how delivery of motivational/coaching messages to justice-involved youth and their caregivers will lead to greater youth substance use treatment attendance and engagement. The study will start with identifying the feasibility and acceptability of the SMS text-messaging intervention with community-supervised justice-involved youth. Then, the study will determine whether the tailored dyadic (youth and caregiver) "SMS text-messaging plus" intervention (appointment reminder texts plus motivational message texts) improves youth substance use or dual diagnosis treatment attendance and engagement relative to the "SMS text messaging" comparison (only appointment reminder texts). Finally, the study will characterize patterns of key justice and behavioral health system-level factors that promote or hinder eventual adoption and sustainability of mHealth technology as a tool to improve treatment attendance for justice-involved youth.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Francisco, California, United States, 94131
        • UCSF Zuckerberg San Francisco General Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 14 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • English-speaking youth with willing adult caregiver
  • Ages 13-18
  • Justice-involved while living in the community
  • Own a mobile phone or tablet
  • Are willing to send and receive text messages
  • Are referred to community-based substance use and/or mental health treatment

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SMS Text Messaging Plus
SMS text messaging intervention for a period of 90 days to encourage attendance at community-based substance use or dual diagnosis treatment appointments through treatment appointment reminders plus motivational messages
SMS text messaging intervention for a period of 90 days to encourage attendance at community-based substance use or dual diagnosis treatment appointments through treatment appointment reminders plus motivational messages
Active Comparator: SMS Text Messaging
SMS text messaging intervention for a period of 90 days that included only treatment appointment reminders
SMS text messaging intervention for a period of 90 days that included only treatment appointment reminders

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment Attendance
Time Frame: 90 days post baseline
Youth's percentage of treatment sessions attended as separately self-reported by youth and caregivers.
90 days post baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alcohol Use
Time Frame: 90 days post baseline
The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) alcohol use. These data represent the number of youth who endorsed any alcohol use in the past 90 days
90 days post baseline
Drug Use
Time Frame: 90 days post baseline
The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) cannabis and other drug use. These data represent the number of youth who endorsed any drug use in the past 90 days
90 days post baseline
Tobacco Use
Time Frame: 90 days post baseline
The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) cannabis and other drug use. These data represent the number of youth who endorsed any tobacco use in the past 90 days
90 days post baseline
In Mental Health Treatment at 90 Day Follow up
Time Frame: 90 days post baseline
Treatment Status and Attendance Youth survey is used to gather detailed information about type of treatment the youth is attending.
90 days post baseline
In Substance Use Treatment at 90 Day Follow up
Time Frame: 90 days post baseline
Treatment Status and Attendance Youth survey is used to gather detailed information about type of treatment the youth is attending.
90 days post baseline
In Dual Diagnosis (Mental Health and Substance Use) Treatment at 90 Day Follow up
Time Frame: 90 days post baseline
Treatment Status and Attendance Youth survey is used to gather detailed information about type of treatment the youth is attending.
90 days post baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Alcohol use
Time Frame: 90 days post baseline
The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) alcohol use.
90 days post baseline
Alcohol use
Time Frame: 180 days post baseline
The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) alcohol use.
180 days post baseline
Drug use
Time Frame: 90 days post baseline
The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) cannabis and other drug use.
90 days post baseline
Drug use
Time Frame: 180 days post baseline
The Adolescent Risk Behavior Assessment (ARBA) is used to assess quantity and frequency of previous (lifetime and past 90 days) cannabis and other drug use.
180 days post baseline
Drug Use
Time Frame: 90 days post baseline
The Texas Christian University (TCU) Drug Screen with Opioid Supplement is used to gather detailed information about drug and opioid use.
90 days post baseline
Drug Use
Time Frame: 180 days post baseline
The Texas Christian University (TCU) Drug Screen with Opioid Supplement is used to gather detailed information about drug and opioid use.
180 days post baseline
Response rate to SMS messages
Time Frame: 30 days post baseline
Digital (mobile) health metrics
30 days post baseline
Response rate to SMS messages
Time Frame: 60 days post baseline
Digital (mobile) health metrics
60 days post baseline
Response rate to SMS messages
Time Frame: 90 days post baseline
Digital (mobile) health metrics
90 days post baseline
Psychiatric symptoms
Time Frame: 90 days post baseline
Global Appraisal of Individual Needs-Short Screener (GAIN-SS) is used to identify people with recent and lifetime internalizing and externalizing mental health disorders, substance use disorders and crime/violence problems. GAIN-SS responses are given in terms of the recency of the problem described in the questions: 3 = past month; 2 = 2 to 12 months ago; 1 = 1+ years ago; 0 = never. The number of past-month symptoms (number of 3s) is used as a measure of change; the number of past-year symptoms (number of 3s or 2s) is used to identify who is likely to have a current diagnosis; and the number of lifetime symptoms (number of 3s, 2s, or 1s) is used as a covariate measure of lifetime severity.
90 days post baseline
Psychiatric symptoms
Time Frame: 180 days post baseline
Global Appraisal of Individual Needs-Short Screener (GAIN-SS) is used to identify people with recent and lifetime internalizing and externalizing mental health disorders, substance use disorders and crime/violence problems. GAIN-SS responses are given in terms of the recency of the problem described in the questions: 3 = past month; 2 = 2 to 12 months ago; 1 = 1+ years ago; 0 = never. The number of past-month symptoms (number of 3s) is used as a measure of change; the number of past-year symptoms (number of 3s or 2s) is used to identify who is likely to have a current diagnosis; and the number of lifetime symptoms (number of 3s, 2s, or 1s) is used as a covariate measure of lifetime severity.
180 days post baseline
Therapeutic Alliance
Time Frame: 30 days post baseline
The Working Alliance Inventory (WAI) is used to assess youth's perception of therapeutic alliance (with treatment provider) over time. Scores range from 12 to 84 with higher scores indicating greater perceived therapeutic alliance.
30 days post baseline
Therapeutic Alliance
Time Frame: 60 days post baseline
The Working Alliance Inventory (WAI) is used to assess youth's perception of therapeutic alliance (with treatment provider) over time. Scores range from 12 to 84 with higher scores indicating greater perceived therapeutic alliance.
60 days post baseline
Therapeutic Alliance
Time Frame: 90 days post baseline
The Working Alliance Inventory (WAI) is used to assess youth's perception of therapeutic alliance (with treatment provider) over time. Scores range from 12 to 84 with higher scores indicating greater perceived therapeutic alliance.
90 days post baseline
Therapeutic Alliance
Time Frame: 120 days post baseline
The Working Alliance Inventory (WAI) is used to assess youth's perception of therapeutic alliance (with treatment provider) over time. Scores range from 12 to 84 with higher scores indicating greater perceived therapeutic alliance.
120 days post baseline
Therapeutic Alliance
Time Frame: 180 days post baseline
The Working Alliance Inventory (WAI) is used to assess youth's perception of therapeutic alliance (with treatment provider) over time. Scores range from 12 to 84 with higher scores indicating greater perceived therapeutic alliance.
180 days post baseline
Treatment Motivation
Time Frame: 30 days post baseline
The Motivation for Youth's Treatment Scale (MYTS) is used to measure intrinsic treatment motivation.
30 days post baseline
Treatment Motivation
Time Frame: 60 days post baseline
The Motivation for Youth's Treatment Scale (MYTS) is used to measure intrinsic treatment motivation.
60 days post baseline
Treatment Motivation
Time Frame: 90 days post baseline
The Motivation for Youth's Treatment Scale (MYTS) is used to measure intrinsic treatment motivation.
90 days post baseline
Treatment Motivation
Time Frame: 120 days post baseline
The Motivation for Youth's Treatment Scale (MYTS) is used to measure intrinsic treatment motivation.
120 days post baseline
Treatment Motivation
Time Frame: 180 days post baseline
The Motivation for Youth's Treatment Scale (MYTS) is used to measure intrinsic treatment motivation.
180 days post baseline
Characteristics of Communication and Interaction with Probation Officers and Treatment Providers
Time Frame: 30 days post baseline
Questions on communication characteristics will identify the preferred modes and patterns of communication between caregivers/youth and probation officers/treatment providers.
30 days post baseline
Characteristics of Communication and Interaction with Probation Officers and Treatment Providers
Time Frame: 60 days post baseline
Questions on communication characteristics will identify the preferred modes and patterns of communication between caregivers/youth and probation officers/treatment providers.
60 days post baseline
Characteristics of Communication and Interaction with Probation Officers and Treatment Providers
Time Frame: 90 days post baseline
Questions on communication characteristics will identify the preferred modes and patterns of communication between caregivers/youth and probation officers/treatment providers.
90 days post baseline
Characteristics of Communication and Interaction with Probation Officers and Treatment Providers
Time Frame: 120 days post baseline
Questions on communication characteristics will identify the preferred modes and patterns of communication between caregivers/youth and probation officers/treatment providers.
120 days post baseline
Characteristics of Communication and Interaction with Probation Officers and Treatment Providers
Time Frame: 180 days post baseline
Questions on communication characteristics will identify the preferred modes and patterns of communication between caregivers/youth and probation officers/treatment providers.
180 days post baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marina Tolou-Shams, PhD, University of California, San Francisco

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2020

Primary Completion (Actual)

April 1, 2025

Study Completion (Actual)

April 1, 2025

Study Registration Dates

First Submitted

May 7, 2020

First Submitted That Met QC Criteria

June 22, 2020

First Posted (Actual)

June 25, 2020

Study Record Updates

Last Update Posted (Actual)

September 1, 2026

Last Update Submitted That Met QC Criteria

August 28, 2026

Last Verified

August 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 1K24DA046569-01A1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe